fetal liver-derived mesenchymal stem cells
Cell therapyexperimental
Clinical trial activity
3 trials · 11 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 28, 2007 (NCT01013194)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04623606 | Phase 1/Phase 2 (Phase 2) | May 20, 2019 | Christian Medical College, Vellore, India, Government of India, Karolinska Institute, Vinnova |
| NCT03706482 | Phase 1/Phase 2 (Phase 2) | May 1, 2019 | Karolinska Institute, Leiden University, Lund University, University of Cologne, University of London, Utrecht University |
| NCT01013194 | Phase 1/Phase 2 (Phase 2) | Feb 28, 2007 | The Mediterranean Institute for Transplantation and Advanced Specialized Therapies, University of Pittsburgh |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Karolinska Institute | Academic/Hospital | 2 | 1 | 1 | 2019 |
| Christian Medical College, Vellore, India | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Government of India | Government | 1 | 0 | 1 | 2019 |
| Leiden University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| The Mediterranean Institute for Transplantation and Advanced Specialized Therapies | Academic/Hospital | 1 | 1 | 1 | 2007 |
| University of Cologne | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2019 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Utrecht University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Vinnova | Government | 1 | 0 | 1 | 2019 |
11 organizations
Page 1 / 1